Deepak Cyril D’Souza

2.2k total citations
30 papers, 1.4k citations indexed

About

Deepak Cyril D’Souza is a scholar working on Cellular and Molecular Neuroscience, Pharmacology and Molecular Biology. According to data from OpenAlex, Deepak Cyril D’Souza has authored 30 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 13 papers in Pharmacology and 9 papers in Molecular Biology. Recurrent topics in Deepak Cyril D’Souza's work include Neurotransmitter Receptor Influence on Behavior (9 papers), Nicotinic Acetylcholine Receptors Study (8 papers) and Tryptophan and brain disorders (7 papers). Deepak Cyril D’Souza is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (9 papers), Nicotinic Acetylcholine Receptors Study (8 papers) and Tryptophan and brain disorders (7 papers). Deepak Cyril D’Souza collaborates with scholars based in United States, South Korea and Sweden. Deepak Cyril D’Souza's co-authors include John H. Krystal, Walid Abi‐Saab, Steven Madonick, Edward Perry, Bita Moghaddam, Ralitza Gueorguieva, Kenneth R. Pugh, Pawel Skudlarski, W. Einar Mencl and Leslie K. Jacobsen and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Molecular Psychiatry.

In The Last Decade

Deepak Cyril D’Souza

29 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Deepak Cyril D’Souza United States	19	618	450	404	397	349	30	1.4k
Takeshi Izumi Japan	26	893 1.4×	568 1.3×	472 1.2×	219 0.6×	232 0.7×	84	1.8k
Tai‐Jui Chen Taiwan	23	649 1.1×	437 1.0×	319 0.8×	239 0.6×	285 0.8×	39	1.6k
Steven Madonick United States	13	739 1.2×	344 0.8×	268 0.7×	637 1.6×	509 1.5×	15	1.5k
Gerald Valentine United States	18	499 0.8×	300 0.7×	398 1.0×	299 0.8×	159 0.5×	27	1.6k
Matthew S. Milak United States	24	663 1.1×	563 1.3×	308 0.8×	763 1.9×	312 0.9×	49	2.0k
Joseph H. Porter United States	20	944 1.5×	323 0.7×	451 1.1×	275 0.7×	321 0.9×	89	1.7k
Nicole DellaGioia United States	16	456 0.7×	315 0.7×	281 0.7×	396 1.0×	252 0.7×	28	2.1k
Kaori Koike Japan	14	873 1.4×	443 1.0×	361 0.9×	173 0.4×	182 0.5×	22	1.7k
Suham Kassir United States	21	948 1.5×	203 0.5×	481 1.2×	470 1.2×	364 1.0×	39	1.9k
Jennifer A. DiNieri United States	11	645 1.0×	262 0.6×	501 1.2×	469 1.2×	211 0.6×	12	1.7k

Countries citing papers authored by Deepak Cyril D’Souza

Since Specialization

Citations

This map shows the geographic impact of Deepak Cyril D’Souza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepak Cyril D’Souza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepak Cyril D’Souza more than expected).

Fields of papers citing papers by Deepak Cyril D’Souza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepak Cyril D’Souza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepak Cyril D’Souza. The network helps show where Deepak Cyril D’Souza may publish in the future.

Co-authorship network of co-authors of Deepak Cyril D’Souza

This figure shows the co-authorship network connecting the top 25 collaborators of Deepak Cyril D’Souza. A scholar is included among the top collaborators of Deepak Cyril D’Souza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepak Cyril D’Souza. Deepak Cyril D’Souza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Surti, Toral, Mohini Ranganathan, Jason Johannesen, et al.. (2023). Randomized controlled trial of the glycine transporter 1 inhibitor PF-03463275 to enhance cognitive training and neuroplasticity in schizophrenia. Schizophrenia Research. 256. 36–43. 7 indexed citations

Aquino, João P. De, Anees Bahji, & Deepak Cyril D’Souza. (2021). Letter to the Editor: Cannabis as a Solution to the Opioid Crisis: Is the Cart Before the Horse Again?. Cannabis and Cannabinoid Research. 7(6). 898–900. 4 indexed citations

Lu, Yihuan, David Matuskey, Nabeel Nabulsi, et al.. (2021). Assessment of transient dopamine responses to smoked cannabis. Drug and Alcohol Dependence. 227. 108920–108920. 7 indexed citations

Radhakrishnan, Rajiv, Mohini Ranganathan, & Deepak Cyril D’Souza. (2019). Medical Marijuana. The Journal of Clinical Psychiatry. 80(5). 5 indexed citations

Boggs, Douglas L., Toral Surti, Irina Esterlis, et al.. (2017). Minimal effects of prolonged smoking abstinence or resumption on cognitive performance challenge the “self-medication” hypothesis in schizophrenia. Schizophrenia Research. 194. 62–69. 29 indexed citations

Boggs, Douglas L., et al.. (2014). Going up in Smoke? A Review of nAChRs-based Treatment Strategies for Improving Cognition in Schizophrenia. Current Pharmaceutical Design. 20(31). 5077–5092. 22 indexed citations

Esterlis, Irina, Mohini Ranganathan, Frédéric Y. Bois, et al.. (2013). In Vivo Evidence for β2 Nicotinic Acetylcholine Receptor Subunit Upregulation in Smokers as Compared With Nonsmokers With Schizophrenia. Biological Psychiatry. 76(6). 495–502. 40 indexed citations

Boggs, Douglas L., et al.. (2013). Treatment of Hyperprolactinemia and Gynecomastia With Adjunctive Aripiprazole in 2 Men Receiving Long-Acting Injectable Antipsychotics. The Primary Care Companion For CNS Disorders. 15(4). 5 indexed citations

D’Souza, Deepak Cyril, Kyung-Heup Ahn, Savita G. Bhakta, et al.. (2012). Nicotine Fails to Attenuate Ketamine-Induced Cognitive Deficits and Negative and Positive Symptoms in Humans: Implications for Schizophrenia. Biological Psychiatry. 72(9). 785–794. 30 indexed citations

10.

Keefe, Richard S.E., Sophia Vinogradov, Alice Medalia, et al.. (2012). Feasibility and Pilot Efficacy Results From the Multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) Randomized Controlled Trial. The Journal of Clinical Psychiatry. 73(7). 1016–1022. 64 indexed citations

11.

Sewell, R. Andrew, Edward Perry, Laurence P. Karper, et al.. (2010). Clinical significance of neurological soft signs in schizophrenia: Factor analysis of the Neurological Evaluation Scale. Schizophrenia Research. 124(1-3). 1–12. 26 indexed citations

12.

Krystal, John H., Sanjay J. Mathew, Deepak Cyril D’Souza, et al.. (2010). Potential Psychiatric Applications of Metabotropic Glutamate Receptor Agonists and Antagonists. CNS Drugs. 24(8). 669–693. 130 indexed citations

13.

Trevisan, Louis, Ismene L. Petrakis, Brian Pittman, et al.. (2007). Absence of Significant Interactive Effects of High‐Dosed‐Cycloserine and Ethanol in Healthy Human Subjects: Preliminary Insights Into Ethanol Actions at the Glycine_BSite of NMDA Glutamate Receptors. Alcoholism Clinical and Experimental Research. 32(1). 36–42. 11 indexed citations

14.

Morgan, Celia J. A., Edward Perry, Hyun Sang Cho, John H. Krystal, & Deepak Cyril D’Souza. (2006). Greater vulnerability to the amnestic effects of ketamine in males. Psychopharmacology. 187(4). 405–414. 40 indexed citations

15.

Krystal, John H., Edward Perry, Ralitza Gueorguieva, et al.. (2005). Comparative and Interactive Human Psychopharmacologic Effects of Ketamine and Amphetamine. Archives of General Psychiatry. 62(9). 985–985. 258 indexed citations

16.

Perry, Edward, Roberto Gil, Lisa Macdougall, et al.. (2005). Mazindol Augmentation of Antipsychotic Treatment for Schizophrenic Patients with Comorbid Cocaine Abuse or Dependence. Journal of Dual Diagnosis. 1(1). 37–47. 6 indexed citations

17.

Cho, Hyun Sang, Deepak Cyril D’Souza, Ralitza Gueorguieva, et al.. (2005). Absence of behavioral sensitization in healthy human subjects following repeated exposure to ketamine. Psychopharmacology. 179(1). 136–143. 33 indexed citations

18.

D’Souza, Deepak Cyril, Roberto Gil, Danielle Abi‐Saab, et al.. (2000). IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans. Biological Psychiatry. 47(5). 450–462. 87 indexed citations

19.

Krystal, John H., Deepak Cyril D’Souza, Steven Madonick, & Ismene L. Petrakis. (1999). Toward a rational pharmacotherapy of comorbid substance abuse in schizophrenic patients. Schizophrenia Research. 35. S35–S49. 72 indexed citations

20.

Abi‐Saab, Walid, Deepak Cyril D’Souza, Bita Moghaddam, & John H. Krystal. (1998). The NMDA Antagonist Model for Schizophrenia: Promise and Pitfalls. Pharmacopsychiatry. 31(S 2). 104–109. 163 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact